BHS 2013 recommendations for treatment of myelodysplastic syndromes
(2015) Belgian Journal of Hematology — Vol. 6, n° 2, p. 54-60 (2015)
Files
MeersSGrauxCBelJHematol2015.pdf
Restricted Access - Adobe PDF
- 3.59 MB
Details
- Authors
- Abstract
- (en) The guidelines on the current state-of-the-art in the diagnosis and treatment of myelodysplastic syndromes of the Belgian Hematological Society working group on myelodysplastic syndromes were published in 2013.1 The key points of these guidelines are presented in two issues of the Belgian Journal of Hematology. In this paper we present the optimal treatment of patients with myelodysplastic syndromes within the current limitations of Belgian reimbursement modalities
- Affiliations
Citations
Meers, S., Breems, D., Bries, G., Delforge, M., Graux, C., Selleslag, D., & Noens, L. (2015). BHS 2013 recommendations for treatment of myelodysplastic syndromes. Belgian Journal of Hematology, 6(2), 54-60. https://hdl.handle.net/2078.5/190988 (Original work published 2015)